The recent launch of predictive health company Outcomeus marks a meaningful advance in America's ongoing fight against opioid overdoses and chronic pain. Through Outcomeus, founder and chairman, and Industry maverick Brian Meshkin continues forward in his mission to provide effective pain management solutions, which have contributed to significant gains in resolving the crisis that dates back to 2016. Clinical monitoring patient assessments are now covered by federal health programs like Medicare and Medicaid as well as private insurance plans, in part because of positive clinical outcomes for Medicare beneficiaries from Meshkin's previous venture as well as his recent highly publicized legal victory.
Irvine, California--(Newsfile Corp. - October 25, 2023) - Today at the annual OCTANe Medical Innovation Forum, award-winning executive and social entrepreneur Brian Meshkin announced the launch of predictive health company Outcomeus. Meshkin, who was previously selected as OCTANe's CEO of the Year, detailed to attendees how Outcomeus helps to solve America's dueling public health crises: its most prevalent and expensive health condition-chronic pain-and its most dire preventable cause of death-opioid overdose. Outcomeus is led by a team of proven executives and researchers in the fields of predictive health and chronic pain management. The company's clinical services and proprietary Doality Platform are powered by the world's largest clinical data bank for pain and orthopedics, with over 153,000 patients and 28 billion data points.
Outcomeus Logo
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_001full.jpg
Building Trust and Accountability in Pain Management
Outcomeus empowers clinicians with better insights into their patients' pain management and prescribed pharmaceuticals. By working with Outcomeus, clinicians can extend care virtually into the home.
Outcomeus offers the following clinical services:
- Remote Patient Monitoring (RPM)
- Remote Treatment Monitoring (RTM)
- Chronic Care Pain Management (CCM/CPM)
Outcomeus also offers research services, including outcomes studies, clinical trials, patient recruitment and enrollment, and more.
Using Outcomeus's predictive insights, clinicians were able to successfully counsel patients at high risk for opioid abuse to non-opioids with similar analgesia.
Figure 1
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_002full.jpg
For patients who demonstrate high-risk factors for misusing opioids or who are already taking opioids and may fear a worsening of conditions, Outcomeus's predictive insights and monthly tracking services resulted in patients' achieving analgesic efficacy that was not significantly different than when transitioned to a non-opioid treatment, as advised by the patients' clinicians, who used Outcomeus's analytics platforms and monitoring services.
Results Matter at Outcomeus
Using Outcomeus's monthly monitored predictive insights, patients achieved a near 50% reduction in pain within 30 days, which sustained for months.
Figure 2
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_003full.jpg
Expanded and Enhanced Clinical Outcomes: Outcomeus Supports the Management of Common Co-Morbidities. Avoiding Hospitalizations and Costs.
The most dire co-morbidity is heart disease. In a study of patients with cardiovascular disease, an Outcomeus remote patient-monitoring program resulted in a net reduction in hospital admissions, slowed disease progression, and realized annual cost savings.
Brian Meshkin's History of Delivering Promising Resolutions
Figure 3
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_004full.jpg
The Only Time America's Opioid Overdose Crisis Hit a Plateau and Decreased Was When Meshkin's Previous Company Entered The Market. Outcomeus Has Built On The Services Of The Previous Company And Expects Heightened Efficacy In Resolutions To The Crisis.
A Proven Leader 
Portrait of Brian Meshkin by Brett Colvin
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_005full.jpg
Brian Meshkin Is An Award-Winning Technology Entrepreneur & Executive. Most Notably, Mr. Meshkin:
- Founded and Led The 69th Fastest Growing Company in America.
- He Has Led Companies To Inc 5000.
- Victorious In Fighting For Healthcare Justice Against The Government.
- Has Led The Successful Development And Implementation Of National Safety Laws Which Have Saved The Lives Of Countless Children.
- Has Twice Been Recognized As Entrepreneur Of The Year By E.Y Orange County, California.
Meshkin explains his mission in his own words: "With the dueling public health crises of chronic pain and opioid addiction only getting worse, patients need supportive care and monitoring, clinicians need tools and information to extend care to patients in their homes, and society needs effective, clinically proven outcomes and track records. My-Self and Outcomeus answer this call and, through trials and tests, have availed as victors. There is no place in our lives where outcomes matter more than our health."
Outcomeus Logo
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8945/185201_e709c0f40457cae6_006full.jpg
Media Inquiries:
Republicist
www.Republicist.com
Contact: Everly Marlowe
Title: Media-Director
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/185201